Industry Reports

You have selected:


Publisher:

The Assessment Group

Sort By:
Report Status:
9 Report Results
Page 1 of 1
Go To Page:
    
  Go

US Market Changes in the Treatment of Advanced Lung Cancer

$2,900.00
By:
, Published: Sep-2012

The purpose of this study is to examine changes in the market for therapeutics used in the treatment of advanced lung cancer by examining longitudinal practice patterns of oncologists. Progressively unfolding patient case scenarios were presented to 152 U.S. oncologists for their responses to open-ended questions concerning their choices of treatment regimens, factors that influence their decisions, barriers to optimal patient treatment and c.....

US Market Changes in the Treatment of Advanced Prostate Cancer

$2,900.00
By:
, Published: Sep-2012

Progressively unfolding patient case scenarios were presented to 151 U.S. oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment choices, factors that influence their decisions, barriers to optimal treatment and confidence in treatment and management of patients. This survey was conducted in 2011 and 2012 to compare oncology practice patterns and determine t.....

US Market Changes in the Treatment of Advanced Breast Cancer

$2,900.00
By:
, Published: Sep-2012

A survey with unfolding patient case scenarios was presented to 180 U.S. oncologists who manage patients with metastatic breast cancer for their open-ended responses. In each case, oncologists were asked to respond to questions concerning their choices of treatment regimens, factors that influenced their decisions, barriers to optimal patient treatment and confidence in treatment and management of patients. This survey was conducted in 2011 an.....

US Market Changes in the Treatment of Non-Hodgkin’s Lymphoma

$2,900.00
By:
, Published: Sep-2012

The purpose of this research study is to examine the current and evolving practice patterns of oncologists in managing advanced non-Hodgkin’s lymphoma. A survey with unfolding patient case scenarios was presented to 158 U.S. oncologists for their open-ended responses to questions concerning their choices of treatment regimens, factors that influenced their decisions, barriers to optimal patient treatment and confidence in treatment and manage.....

US Market Changes in the Treatment of Advanced Melanoma

$2,900.00
By:
, Published: Sep-2012

Progressively unfolding patient case scenarios were presented to 200 U.S. oncologists, who manage patients with advanced melanoma, to understand differences in clinical decisions and the factors that influence those decisions. Data presented includes oncologist treatment regimen choices, factors that influence their decisions, barriers to optimal patient care and confidence in patient treatment. This report identifies market changes based o.....

US Oncologist Survey: Optimizing Treatment for Advanced Non-Hodgkin’s Lymphoma

$8,900.00
By:
, Published: Apr-2011

Experience real patient situations that progressively unfold, presented to a representative sample of 158 US oncologists who manage 11 or more patients monthly with non-Hodgkin’s lymphoma. Oncologists were presented with four patient case scenarios and asked to respond to open-ended questions concerning their choices of treatment regimens, factors that influenced their decisions, and barriers to optimal patient management. This primary researc.....

US Oncologist Survey: Optimizing Treatment for Stage IIIA Asymptomatic Indolent Lymphoma

$2,999.00
By:
, Published: Apr-2011

Patient specific case scenario on advanced non-Hodgkin’s lymphoma in a situation involving a patient with Stage IIIA Asymptomatic Indolent Lymphoma that progresses throughout the report, presented to 158 high-prescribing oncologists for their open responses on clinical decisions. Patient progression reveals:

Decisions in treatment and tests through disease stages

Factors influencing their decisions

Barriers to optimal patien.....

US Oncologist Survey: Optimizing Treatment for Large Cell Lymphoma

$2,999.00
By:
, Published: Apr-2011

Two patient specific case scenarios on advanced non-Hodgkin’s lymphoma involving patients with a) relapsed large cell lymphoma and b) large cell lymphoma with compromised cardiac function that progresses throughout the report, presented to 158 high-prescribing oncologists for their open responses on clinical decisions. Patient progressions reveal:

Decisions in treatment and tests through disease stages

Factors influencing their .....

US Oncologist Survey: Optimizing Treatment for Stage IV Follicular B-Cell Non-Hodgkin’s Lymphoma

$2,999.00
By:
, Published: Apr-2011

A patient specific case scenario on advanced non-Hodgkin’s lymphoma involving a patient with stage IV follicular B-cell that progresses throughout the report, presented to 158 high-prescribing oncologists for their open responses on clinical decisions. Patient progressions reveal:

Decisions in treatment and tests through disease stages

Factors influencing their decisions

Barriers to optimal patient care

Confidence in t.....